- ¥2980
- LMAI Bio
- LM-2550R-FITC
- 中国/美国/欧洲
- 2025年07月12日
- IF=1:50-200
- Human, Mouse, Rat, Pig,
- Human, Mouse, Rat, Pig,
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海联迈生物工程有限公司
- 库存：
大量
- 靶点：
详见说明书
- 级别：
1
- 目录编号：
LM-2550R-FITC
- 克隆性：
多克隆
- 抗原来源：
Rabbit
- 保质期：
1年
- 抗体英文名：
Anti-NAP2/FITC
- 抗体名：
Anti-NAP2/FITC
- 标记物：
FITC标记
- 宿主：
Human, Mouse, Rat, Pig,
- 适应物种：
Human, Mouse, Rat, Pig,
- 免疫原：
详见说明书
- 亚型：
IGg
- 形态：
粉末、液体、冻干粉
- 应用范围：
IF=1:50-200
- 浓度：
1mg/ml
- 保存条件：
-20 °C
- 规格：
100ul
| 英文名称 | Anti-NAP2/FITC |
| 中文名称 | FITC标记的中性粒细胞活性蛋白2/血小板碱性蛋白抗体 |
| 别 名 | B TG1; Beta TG; b-TG1; beta-TG; NAP-2; NAP2; NAP 2; Beta thromboglobulin; Chemokine (C X C motif) ligand 7; Connective tissue activating peptide III; CTAP 3; CTAP III; CTAP3; CTAPIII; CXC chemokine ligand 7; CXCL 7; CXCL7; LA PF 4; LA-PF4; LDGF; Leukocyte derived growth factor; Low affinity platelet factor IV; MDGF; NAP 2; NAP-2; NAP 2 L1; Neutrophil activating peptide 2; PBP; Platelet basic protein; Platelet basic protein precursor; PPBP; Pro platelet basic protein; SCYB7; Small inducible cytokine B7; Small inducible cytokine subfamily B member 7; TC1; TC2; TGB; TGB1; THBGB; THBGB1; Thrombocidin 1; Thrombocidin 2; Thromboglobulin beta 1. |
| 规格价格 | 100ul/2980元 购买 大包装/询价 |
| 说 明 书 | 100ul |
| 研究领域 | 心血管 细胞生物 免疫学 信号转导 生长因子和激素 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Mouse, Rat, Pig, |
| 产品应用 | IF=1:50-200 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 14kDa |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from mouse CXCL7 |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 产品介绍 | background: The protein encoded by this gene is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells. [provided by RefSeq, May 2010]. Function: LA-PF4 stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by human synovial cells. NAP-2 is a ligand for CXCR1 and CXCR2, and NAP-2, NAP-2(73), NAP-2(74), NAP-2(1-66), and most potent NAP-2(1-63) are chemoattractants and activators for neutrophils. TC-1 and TC-2 are antibacterial proteins, in vitro released from activated platelet alpha-granules. CTAP-III(1-81) is more potent than CTAP-III desensitize chemokine-induced neutrophil activation. Subunit: Beta-thromboglobulin is a homotetramer. Subcellular Location: Secreted. Post-translational modifications: Proteolytic removal of residues 1-9 produces the active peptide connective tissue-activating peptide III (CTAP-III) (low-affinity platelet factor IV (LA-PF4)). Proteolytic removal of residues 1-13 produces the active peptide beta-thromboglobulin, which is released from platelets along with platelet factor 4 and platelet-derived growth factor. NAP-2(1-66) is produced by proteolytical processing, probably after secretion by leukocytes other than neutrophils. NAP-2(73) and NAP-2(74) seem not be produced by proteolytical processing of secreted precursors but are released in an active form from platelets. Similarity: Belongs to the intercrine alpha (chemokine CxC) family. Database links: Entrez Gene: 5473 Human Omim: 121010 Human SwissProt: P02775 Human Unigene: 2164 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验/α亚族，主要趋化中性粒细胞，包括IL-8、黑素瘤细胞生长刺激活性(GRO/MGSA）、血小板因子-4（PF-4）、血小板碱性蛋白、蛋白水解来源的产物CTAP-III和β-thromboglobulin、炎症蛋白10（IP-10）、ENA-78；（2）C-C/β亚族，主要趋化单核细胞，包括巨噬细胞炎症蛋白1α（MIP-1α）、MIP-1β、RANTES、单核细胞趋化蛋白-1（MCP-1/MCAF）、MCP-2、MCP-3和I-309。 7.其它细胞因子，如表皮生长因子（EGF）、血小板衍生
研究的又一里程碑。 （一）历史回顾 Strubing 早在一个世纪之前，就第一次报告了 PNH ，症状为溶血性贫血，伴有夜间血红蛋白尿。 50 年后， Ham 和 Dingle 证明了 PNH 患者的红细胞在血清酸化条件下，易发生溶血，这就是现在普遍使用的 Ham 实验，用来诊断 PNH 。不久，又发现 PNH 的溶血是由于患者的红细胞对补体敏感。进而又发现 PNH 患者的中性粒细胞和血小板也有异常。 Dacie 在 1963 年提出了 PNH 是由于干细
产生的IgE可与嗜碱性粒细胞、肥大细胞表面IgE高亲力受体细胞脱颗粒，释放组胺，合成由细胞FcεRI结合。当相同的变应原再次进入机体时，可与已固定在细胞膜上的IgE结合，刺激细胞脱颗粒，释放组受，合成由细胞脂质来源的介质如白三烯、前列腺素、血小板活化因子等，引起Ⅰ型变态反应。 2．调理吞噬作用 调理作用（opsonization）是指抗体、补体C3b、C4b等调理素(opsonin)促进吞噬细菌等颗粒性抗原。由于补体对热不稳定，因此又称为热不稳定调理素（heat-labile
技术资料暂无技术资料 索取技术资料
